Abstract
New psychoactive substances (NPS) have emerged in a threatening way in the last decades. They are sold via the internet or head shops with several names (bath salts, Research chemical, RCs, Legal Highs) and forms (pills, tablets, powder...etc.), and are labelled ambiguously to escape governmental legislation. Designer drugs belong to different chemical classes, but cathinones derivatives presented the most prevalent group. In 2013, this group accounted for 30% of NPS seizures in Europe with more than 450 different compounds, including 101 new molecules reported for the first time in 2014. The increased number of NPS as being sold in parallel market has led several countries to adopt different strategies either on individual surveillance of new emerging drugs or more efficiently on generic control regrouping a wide number of isomers and structurally similar compounds. The identification of these substances is a challenge for toxicologists, which requires sensitive and specific analytical methods based on LC-MS/MS or GC-MS. The usefulness of hair as an alternative matrix for prevalence studies was proved since it offers an overview on drug exposure with a large detection window over weeks or even months and years according to the length of the hair strand. However, as for many drugs of abuse, prevalence studies on cathinones derivatives use are still scarce. Self-reported use or case reports provide most of the available data.
The aim of this paper is to provide an update review on prevalence and surveillance of synthetic cathinones use conducted by hair analysis, excluding case report.
Keywords: New psychoactive substances, designer drugs, bath salts, hair, alternative biological matrix, prevalence, mass spectrometry, synthetic cathinones.
Current Pharmaceutical Design
Title:Prevalence and Surveillance of Synthetic Cathinones Use by Hair Analysis: An Update Review
Volume: 23 Issue: 36
Author(s): Jean-Claude Alvarez*, Nicolas Fabresse and Islam A. Larabi
Affiliation:
- Department of Pharmacology and Toxicology, Versailles Saint-Quentin-en-Yvelines University, Inserm U-1173, Raymond Poincare hospital, AP-HP, Garches,France
Keywords: New psychoactive substances, designer drugs, bath salts, hair, alternative biological matrix, prevalence, mass spectrometry, synthetic cathinones.
Abstract: New psychoactive substances (NPS) have emerged in a threatening way in the last decades. They are sold via the internet or head shops with several names (bath salts, Research chemical, RCs, Legal Highs) and forms (pills, tablets, powder...etc.), and are labelled ambiguously to escape governmental legislation. Designer drugs belong to different chemical classes, but cathinones derivatives presented the most prevalent group. In 2013, this group accounted for 30% of NPS seizures in Europe with more than 450 different compounds, including 101 new molecules reported for the first time in 2014. The increased number of NPS as being sold in parallel market has led several countries to adopt different strategies either on individual surveillance of new emerging drugs or more efficiently on generic control regrouping a wide number of isomers and structurally similar compounds. The identification of these substances is a challenge for toxicologists, which requires sensitive and specific analytical methods based on LC-MS/MS or GC-MS. The usefulness of hair as an alternative matrix for prevalence studies was proved since it offers an overview on drug exposure with a large detection window over weeks or even months and years according to the length of the hair strand. However, as for many drugs of abuse, prevalence studies on cathinones derivatives use are still scarce. Self-reported use or case reports provide most of the available data.
The aim of this paper is to provide an update review on prevalence and surveillance of synthetic cathinones use conducted by hair analysis, excluding case report.
Export Options
About this article
Cite this article as:
Alvarez Jean-Claude*, Fabresse Nicolas and Larabi A. Islam , Prevalence and Surveillance of Synthetic Cathinones Use by Hair Analysis: An Update Review, Current Pharmaceutical Design 2017; 23 (36) . https://dx.doi.org/10.2174/1381612823666170704124156
DOI https://dx.doi.org/10.2174/1381612823666170704124156 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Consensus Guideline Based Therapeutic Drug Monitoring (TDM) in Psychiatry and Neurology
Current Drug Delivery Ganglioside Mimicry as a Cause of Guillain-Barre Syndrome
CNS & Neurological Disorders - Drug Targets Remediation of Cellular Hypoxic Damage by Pharmacological Agents
Current Pharmaceutical Design Disaster Psychiatry: Good Intentions Seeking Science and Sustainability
Adolescent Psychiatry Proteomic Approaches to Study the Pig Intestinal System
Current Protein & Peptide Science Pharmacomodulation of microRNA Expression in Neurocognitive Diseases: Obstacles and Future Opportunities
Current Neuropharmacology Recent Developments in Deception Research
Current Psychiatry Reviews A Review of Eugenol-based Nanomedicine: Recent Advancements
Current Bioactive Compounds The Aromatic Stacking Interactions Between Proteins and their Macromolecular Ligands
Current Protein & Peptide Science Opportunities to Improve the Prevention and Treatment of Cervical Cancer
Current Molecular Medicine Green Tea (Camellia sinensis) Protects Against Arsenic Neurotoxicity via Antioxidative Mechanism and Activation of Superoxide Dismutase Activity
Central Nervous System Agents in Medicinal Chemistry Ligand Recognition by Drug-Activated Nuclear Receptors PXR and CAR: Structural, Site-Directed Mutagenesis and Molecular Modeling Studies
Mini-Reviews in Medicinal Chemistry Biological Relevance of Lysophospholipids and Green Solutions for Their Synthesis
Current Organic Chemistry Eigenanatomy on Fractional Anisotropy Imaging Provides White Matter Anatomical Features Discriminating Between Alzheimer’s Disease and Late Onset Bipolar Disorder
Current Alzheimer Research Solution-Phase Parallel Synthesis of N-Substituted Isoquinuclidines
Letters in Drug Design & Discovery α-Synuclein Aggregation
Protein & Peptide Letters Targeted Therapies in Solid Tumours: Pinpointing the Tumours Achilles Heel
Current Pharmaceutical Design Controlling Apoptosis by Inhibition of Caspases
Current Medicinal Chemistry An Update of the Oxidation-Inflammation Theory of Aging: The Involvement of the Immune System in Oxi-Inflamm-Aging
Current Pharmaceutical Design Reproduction in Couples with Chronic Viral Infections
Current Women`s Health Reviews